Dress Syndrome - A Case Report

1. Allam JP, Paus T, Reichel C, Bieber T, Novak N. DRESS syndrome associated with carbamazepine and phenytoin. Eur J Dermatol. 2004;14(5):339–42.Search in Google Scholar

2. Seth D, Kamat D, Montejo J. DRESS syndrome: a practical approach for primary care practitioners. Clin Pediatr. 2008;47(9):947–52.10.1177/0009922808320703Search in Google Scholar

3. Buck ML. DRESS syndrome: examples from the pediatric literature. Pediatr Pharm. 2012;18(11).Search in Google Scholar

4. Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med. 1995;155(21):2285-90.10.1001/archinte.1995.00430210033005Search in Google Scholar

5. Tennis P, Stern RS. Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine or sodium valproate: a record linkage study. Neurology. 1997;49(2):542-6.10.1212/WNL.49.2.542Search in Google Scholar

6. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity (Drug rash with eosinophilia and systemic symptoms: DRESS). Semin Cutan Med Surg. 1996;15(4):250–7.10.1016/S1085-5629(96)80038-1Search in Google Scholar

7. Criado PR, Criado RF, Avancini JM, Santi CG. Drug reaction with eosinophilia and systemic symptoms (DRESS)/drug-induced hypersensitivity syndrome (DIHS): a review of current concepts. An Bras Dermatol. 2012;87(3):435–49.10.1590/S0365-0596201200030001322714760Search in Google Scholar

8. Lee JY, Seol YJ, Shin DW, Kim DY, Chun HW, Kim BY, et al. A case of the Drug Reaction with Eosinophilia and Systemic Synptom (DRESS) following isoniazid treatment. Tuberc Respir Dis (Seoul). 2015;78(1):27–30.10.4046/trd.2015.78.1.27431103225653694Search in Google Scholar

9. Choudhary S, McLeod M, Torchia D, Romanelli P. Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome. J Clin Aesthet Dermatol. 2013;6(6):31–7.Search in Google Scholar

10. Ganeva M, Gancheva T, Lazarova R, Troeva J, Baldaranov I, Vassilev I, et al. Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review. Int J Dermatol. 2008;47(8):853-60.10.1111/j.1365-4632.2008.03637.x18717872Search in Google Scholar

11. Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA. 2005;102(11):4134–9.10.1073/pnas.040950010255481215743917Search in Google Scholar

12. Kennebeck GA. Anticonvulsant hypersensitivity syndrome. J Am Board Fam Pract. 2000:13(5):364-70.Search in Google Scholar

13. Peyriere H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, et al. Variability in the clinical pattern of cutaneous side effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2006;155(2):422-8.10.1111/j.1365-2133.2006.07284.x16882184Search in Google Scholar

14. Mansur AT, Pekcan Yasar S, Goktay F. Anticonvulsant hypersensitivity syndrome: clinical and laboratory features. Int J Dermatol. 2008;47(11):1184-9.10.1111/j.1365-4632.2008.03827.x18986457Search in Google Scholar

15. Goodwin G, Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2003;17(2):149-73.10.1177/026988110301700200312870562Search in Google Scholar

16. Ruble J, Matsuo F. Anticonvulsant-induced cutaneous reactions. Incidence, mechanisms and management. CNS Drugs. 1999;12(3):215-36.10.2165/00023210-199912030-00005Search in Google Scholar

17. Valencak J, Ortiz-Urda S, Heere-Ress E, Kunstfeld R, Base W. Carbamazepine-induced DRESS syndrome with recurrent fever ant exanthema. Int J Dermatol. 2004;43(1):51-4.10.1111/j.1365-4632.2004.01832.x14693022Search in Google Scholar